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Abstract
CD4+ T cells subsets have a wide range of important helper and regulatory functions in the
immune system. Several studies have specifically suggested that circulating effector CD4+
T cells may play a direct role in control of HIV replication through cytolytic activity or autocrine β-chemokine production. However, it remains unclear whether effector CD4+ T cell
expressing cytolytic molecules and β-chemokines are present within lymph nodes (LNs), a
major site of HIV replication. Here, we report that expression of β-chemokines and cytolytic
molecules are enriched within a CD4+ T cell population with high levels of the T-box transcription factors T-bet and eomesodermin (Eomes). This effector population is predominately found in peripheral blood and is limited in LNs regardless of HIV infection or treatment
status. As a result, CD4+ T cells generally lack effector functions in LNs, including cytolytic
capacity and IFNγ and β-chemokine expression, even in HIV elite controllers and during
acute/early HIV infection. While we do find the presence of degranulating CD4+ T cells in
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LNs, these cells do not bear functional or transcriptional effector T cell properties and are
inherently poor to form stable immunological synapses compared to their peripheral blood
counterparts. We demonstrate that CD4+ T cell cytolytic function, phenotype, and programming in the peripheral blood is dissociated from those characteristics found in lymphoid tissues. Together, these data challenge our current models based on blood and suggest
spatially and temporally dissociated mechanisms of viral control in lymphoid tissues.

Author summary
CD4+ T cells have classically been divided into different subsets based on their different
abilities to help and regulate specific parts of the immune system. Recent work in the HIV
field has demonstrated that HIV-specific CD4+ T cells with unique effector functions,
such as cytolytic activity and β-chemokine production, can play a direct role in control of
HIV replication. However, HIV infection is generally considered to be a disease centered
in lymphoid tissues, where unique CD4+ T helper cell subsets are present to orchestrate
the maturation and priming of adaptive immunity. In this study, we identify that two specific transcription factors, T-bet and Eomes, mark cytolytic and β-chemokine producing
CD4+ T cells. While this effector CD4+ T cell population is part of immunosurveillance
mechanisms in blood, we find that lymph nodes largely lack this effector population–independent of HIV infection or disease progression status. These results indicate that current
effector CD4+ T cell mediated correlates of HIV control are limited to blood and not representative of potential correlates of control in lymphoid tissues.

Introduction
CD4+ T cells are classically known to orchestrate immunity by providing helper functions to
other arms of the immune system. However, CD4+ T cells can also exercise direct cell-to-cell
mediated effector functions to control pathogens and tumors. Effector CD4+ T cells with cytolytic activity are generated during many acute viral infections and represent a front-line
defense in the gut-intraepithelial compartment [1]. Cytolytic CD4+ T cells directly recognize
tumor cells and are involved in host protection against chronic viral infections, such as EBV
and CMV [2]. As HIV has evolved numerous ways to escape recognition by CD8+ T cells and
neutralizing antibodies, it remains important to understand what role effector CD4+ T cells
play to control HIV replication and limit disease progression.
Several studies have demonstrated broad and vigorous responses of peripheral blood HIVspecific CD4+ T cells in untreated individuals with low HIV viremia [3–8]. A growing body of
evidence suggests that increased cytolytic and non-cytolytic mechanisms mediated by highly
differentiated CD4+ T cells are linked to better HIV control. The emergence of HIV-specific
CD4+ T cells with cytolytic properties during early infection has been associated with slower
subsequent disease progression [7, 9]. Furthermore, HIV and SIV elite controllers demonstrate
strong Nef- and Gag-specific CD4+ T cell responses in vivo, that can suppress viral replication
in vitro in both macrophages and CD4+ T cells, potentially through cytolytic activity [9–13].
Late differentiated CD4+ T cells can also mediate non-cytolytic functional mechanisms to
limit CCR5-tropic HIV infection via autocrine production of β-chemokines CCL3 (MIP-1α),
CCL4 (MIP-1β) and CCL5 (RANTES), through either blocking the interaction between gp120
and CCR5 or downregulating CCR5 from the cell surface [14]. In this regard, CMV-specific
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CD4+ T cells are particularly known to be efficient producers of β-chemokines and are notably
preserved in late HIV infection [15–17]. Moreover, elite controllers possess CD4+ T cells resistant to CCR5-tropic HIV, potentially through the impact of increased MIP-1α and MIP-1β
production by these cells [4, 18].
The T-box transcription factors T-bet and eomesodermin (Eomes) regulate effector T cell
differentiation and have been closely associated with the programming of effector functions of
CD8+ T cells (reviewed in [19]) and cytolytic CD4+ T cells [11, 20]. These transcription factors
also have a role in driving CD4+ T cell polarization, where T-bet is particularly known as the
classical Th1 lineage defining transcription factor. Interestingly, T-bet directly regulates many
of the genes encoding CD4+ T cell functions associated with HIV control, including prf1,
gzmb, ccl3, ccl4, and ccl5 are directly regulated by T-bet [21]. Eomes can compensate for the
loss of T-bet to retain effector functions such as IFNγ production [22] and as such can function, to some extent, as a “paralog” to T-bet. We have previously shown that cytolytic CD8+ T
cells have high levels of T-bet and intermediate expression of Eomes in peripheral blood [23];
however, it remains less clear if production of cytolytic granules or β-chemokine by human
CD4+ T cells is similarly coupled to the expression levels of T-bet and Eomes at the single-cell
level.
While considerable evidence suggests that cytolytic and autocrine β-chemokine producing
HIV-specific CD4+ T cells might be involved in control of HIV infection, it remains unclear
whether these cells can mediate antiviral responses within lymphoid tissues, the primary site of
HIV/SIV replication [24]. Here, we sought to directly evaluate the role of effector CD4+ T cellmediated control of viral replication in HIV-infected lymph nodes (LNs) over the course of
HIV infection. We identify a T-bethiEomes+ population that almost exclusively marks cytolytic
and β-chemokine producing CD4+ T cells in blood of healthy and HIV-infected subjects.
However, this population of CD4+ T cells is nearly absent in lymphoid tissues of chronically
infected HIV-infected subjects, suggesting that cytolytic HIV-specific CD4+ T cells are not a
major component of long term viral control in lymphoid tissues.

Results
Cytolytic molecules and β-chemokines are almost exclusively expressed by
T-bethiEomes+ CD4+ T cells
We have previously shown that cytolytic molecule (perforin and Granzyme B) expression in
peripheral blood CD8+ T cells is strongly associated with high expression levels of T-bet (Tbethi) and intermediate expression of Eomes (Eomes+) [23]. Independent of HIV infection status, we found that high levels of T-bet and Eomes expression in CD4+ T cells were also
strongly linked to perforin and Granzyme B expression (Fig 1A and S1 Fig). Expression of
perforin was highly enriched within the T-bethiEomes+ CD4+ T cell population (Fig 1B). Furthermore, the frequency of T-bethi CD4+ T cells correlated strongly with the frequency of perforin+ CD4+ T cells (Fig 1C). Using Imagestream analysis, we found, similar to CD8+ T cells
[25], that T-bet was primarily localized in the nucleus in T-bethi CD4+ T cells, while T-betdim
cells had T-bet more localized in the cytoplasm (Fig 1D), suggesting that T-bet may be transcriptionally active in T-bethi CD4+ T cells. A previous murine study on gut intra-epithelial
CD4+ T cells demonstrated that cytolytic CD4+ T cells can have a ThPokloRunx3hi phenotype
[26]. We found no association between low levels of ThPok expression and the frequency of
Granzyme B+perforin+ CD4+ T cells in blood (S1 Fig). Furthermore, not all Granzyme B+perforin+ CD4+ T cells had a Runx3hi phenotype (S1 Fig).
In order to generate a spatial CD4+ T cell differentiation map, we next used non-linear
dimensional reduction t-SNE analysis by embedding multi-parametric single cell information
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Fig 1. Cytolytic CD4+ T cells express high levels of T-bet and Eomes in blood. (A) Representative flow cytometry plots of Granzyme B and perforin
expression in CD4+ T cells for an HIV-infected and–uninfected subject. The distribution of Granzyme B+perforin+ (red) and Granzyme B-perforin- (blue)
CD4+ T cells are shown for T-bet and Eomes expression. (B) Frequency of perforin+ CD4+ T cells within the T-bethiEomes+ and T-betdim/- population (left)
and T-bethiEomes+ within the perforin+ or perforin- population for HIV-infected and–uninfected subjects. (C) Correlation between the frequency of
perforin+ and T-bethi CD4+ T cells. (D) Imagestream analysis on T-bethi and T-betdim CD4+ T cells. Overlays of fluorescent channels for DAPI (nuclear)
and T-bet, showing where in the cells T-bet are localized. The frequency of nuclear, nuclear/cytoplasmic and cytoplasmic localization for T-bethi and T-betdim
CD4+ T cells are shown in the before-after graphs. (E) tSNE plots based on 30,000 live CD4+ T cells that were merged from three HIV-uninfected subjects
with detectable cytolytic CD4+ T cells. The tSNE clustering is based on CD45RO, CD27, CCR7, T-bet, Eomes, Granzyme A, Granzyme B and perforin
expression intensity. The red gate indicates the identified “effector” cluster with overlapped expression of cytolytic markers as well as T-bet and Eomes. (F)
Flow plots of MIP-1α production using media (NC) and aCD3-CD28 stimulations for T-bethi and Eomes+ CD4+ T cells, as well as correlation between the
frequency of T-bethiEomes+ and MIP-1α+ CD4+ T cells following aCD3-CD28 stimulations. Median and IQR are shown for all scatter plots and MannWhitney tests were performed to compare differences between groups;  P < 0.001. A non-parametric Spearman test was used for the correlations analysis.
All data are derived from the North-American cohort.
https://doi.org/10.1371/journal.ppat.1006973.g001
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from blood CD4+ T cells. The t-SNE analysis generated a plot where the cells with high CCR7
expression were located on one (top) side of the scale, and T-bet and Eomes expressing cells
were on the other (bottom) side of the non-linear dimensional space along with Granzyme A,
Granzyme B and perforin-expressing cells (Fig 1E). Furthermore, single Eomes+ CD4+ T cells
were more early-differentiated (S2 Fig), whereas T-bethiEomes+, as well as single expressing
T-bethi, cells were enriched in more terminally-differentiated CD4+ T cells (S2 Fig). Together,
these data demonstrate that particularly high levels of T-bet marks cytolytic CD4+ T cells.
Autocrine production of β-chemokines has been described to protect CD4+ T cells from
CCR5-tropic HIV infection [15, 16]. Terminally-differentiated CD4+ T cells have generally
been known to produce β-chemokines; however, whether T-bethiEomes+ CD4+ T cells are
specifically the subset capable of producing β-chemokines remains unclear. MIP-1α and MIP1β production were highly co-expressed in CD4+ T cells (S3A Fig), and almost exclusively produced by T-bethiEomes+ CD4+ T cells irrespective of polyclonal (SEB) or antigen (CMVpp65) stimulation (S3B Fig). HIV-specific CD4+ T cells produced low levels of β-chemokines
in most subjects and were therefore not analyzed further [15]. Stimulation with αCD3-CD28
similarly showed that primarily the T-bethiEomes+ cells had the potential to produce MIP-1α
(Fig 1F), and individuals with no T-bethiEomes+ population showed low production of MIP1α (S3C Fig). Likewise, the frequency of T-bethiEomes+ cells correlated strongly with the
aCD3-CD28-activated CD4+ T cells producing MIP-1α (Fig 1F). Both T-betdim and T-bethi
cells expressed IFNγ after SEB and CMV stimulations (S3B and S3C Fig). Although T-betdim
cells can produce IFNγ, individuals that lack T-bethi cells had poor overall IFNγ responses
after αCD3-CD28 stimulations (S3C Fig). Together these data demonstrate that T-bethi cells
have the highest capacity to express cytolytic molecules, β-chemokines and IFNγ and thus represent the major effector CD4+ T cell population in blood.

Peripheral blood T-bethi CD4+ T cells are preserved in HIV-1 infection
The presence of effector CD4+ T cells during acute and chronic HIV infection has been associated with slower disease progression [9]. We first determined the direct impact of HIV-1 infection in vivo on the frequency of T-bet expressing CD4+ T cells in blood. HIV seronegative
individuals (n = 10) that subsequently seroconverted were followed from before infection and
longitudinally up to almost 800 days after the first positive HIV test using the RV217 cohort
[27]. All subjects were untreated during this period of time. Between the initial visit prior to
infection and >1-year post-infection, the median frequency of the T-bethi CD4+ T cell subset
increased by almost 100% (Fig 2A). Further analysis from before infection and longitudinally
during the acute phase of HIV-1 infection revealed that the frequency of T-bethi CD4+ T cells
sharply increased at the first sampled time-points after infection, transiently decreased after
peak viremia, and subsequently slowly increased again (Fig 2B). The expression pattern of
both T-bet and Eomes was further evaluated in a larger cross-sectional European cohort of
HIV-seronegative and -positive subjects, where we found that the median frequency of TbethiEomes+ cells in memory CD4+ T cells was 6.7 times higher in HIV-infected chronic progressors compared to healthy subjects (Fig 2C). Furthermore, T-bethiEomes+ cells were significantly less frequently infected in vitro than other conventional memory (CD45RO+) CD4+ T
cells (S4 Fig), supporting previous studies showing that terminally-differentiated and β-chemokine producing CD4+ T cells contain less HIV-DNA molecules than more early-differentiated CD4+ T cell subsets [15, 28]. We further conducted longitudinal assessments after ART
was initiated and found that the frequency of T-bethiEomes+ cells decreased after ART. However, this drop was associated with an accumulation of naïve cells following ART initiation (S5
Fig), suggesting that the change in frequency is a consequence of naïve cells redistributing in
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Fig 2. Temporal dynamics of T-bethi expression and effector HIV-specific CD4+ T cell responses following HIV
infection in blood. (A) Frequencies of T-bethi CD4+ T cells before and first sample taken 1 year after HIV infection (n = 10).
(B) Longitudinal changes of T-bethi CD4+ T cells before and subsequently after HIV infection. Every individual is depicted
with black connecting lines and red line indicate the estimated mean value (linear regression) over time (n = 10). (C)
Frequency of T-bethi expression on memory CD4+ T cells in HIV- and HIV+ chronic progressors (CP) (D) T-bet, (E)
perforin and (F) MIP-1α expression by IFNγ+ Gag-specific CD4+ T cells before and subsequently following HIV infection
(n = 10). The colored lines represent each subject and their frequencies of T-bethi, perforin+ and MIP-1α+ Gag-specific CD4
+ T cells over time. A Wilcoxon or Mann-Whitney test was performed to compare the difference between groups;  P < 0.05.
Longitudinal data-points are derived from the RV217 cohort and cross-sectional data from the European cohort.
https://doi.org/10.1371/journal.ppat.1006973.g002

blood after ART. Indeed, other data demonstrated that the absolute counts of T-bethiEomes
+ cells did not change longitudinally after ART (S5 Fig), indicating that HIV replication and
rebound have a low impact on the effector CD4+ T cell population in blood. Altogether, these
data suggest that T-bethi CD4+ T cell levels are preserved in blood during HIV infection.
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Elevated effector functions by HIV-specific CD4+ T cells during acute
infection
We next used the RV217 acute cohort to monitor the frequency of T-bet and effector characteristics of HIV-Gag-specific CD4+ T cells from before infection and with close intervals during
acute infection. Early after infection, we found a sharp increase in HIV-specific IFNγ+ CD4+ T
cell responses that later declined (S6 Fig). The very early response at peak viremia was associated
with an effector HIV-specific CD4+ T cell response with elevated levels of T-bet (Fig 2D), perforin (Fig 2E) and MIP-1α (Fig 2F) production. Following peak viremia, however, T-bet expression decreased rapidly, concordant with a subsequent decline of perforin and MIP-1α
production by HIV-specific CD4+ T cells (Fig 2D–2F) demonstrating a close temporal relationship between effector CD4+ T cell responses and T-bet expression following HIV infection.

Dissociated presence of cytolytic CD4+ T cells in peripheral blood
compared to lymph nodes
While peripheral blood CD4+ T cells with an effector profile are preserved in chronic HIV
infection (Fig 2), it remains uncertain if similar cells are present in lymphoid tissues, such as
lymph nodes (LNs), where they could interact with HIV-infected target cells. To determine
this, we first assessed the maturation status (CCR7, CD27, CD45RO) of bulk CD4+ T cells in
blood and LNs (S7A Fig) from HIV-infected and–uninfected individuals. We found that HIV
chronic progressors (CP) and ART-treated (ART+) subjects particularly had elevated levels of
transitional memory (TM) cells in LNs (Fig 3A), which correlated with the expansion of T follicular helper cells (Tfh) (S7B Fig) as previously described for HIV-infected subjects [29, 30].
In contrast, HIV-seronegative subjects had higher levels of TM cells in blood (Fig 3A). Independently of HIV-infection status, both effector memory (EM) cells and terminally-differentiated (TD) cells were significantly reduced in LNs compared to blood (Fig 3A).
Given the decreased levels of terminally-differentiated CD4+ T cells in LNs, we next assessed if
this was further associated with fewer T-bethiEomes+ effector CD4+ T cells in lymphoid tissues
compared to blood. Accordingly, we found very few T-bethiEomes+ CD4+ T cells in LNs for all
groups (Fig 3B). The few Eomes+ cells present in LNs had greatly reduced T-bet expression in contrast to blood-derived CD4+ T cells (Fig 3B). We generally found significantly lower frequencies of
perforin+ and Granzyme B+ CD4+ T cells in LNs compared to peripheral blood independent of
HIV-infection status (Fig 3C). Perforin expression was consistently lower for both LN and blood
CD4+ T cells compared to matched LN and blood CD8+ T cells (S7C Fig). Furthermore, Granzyme B showed low co-expression with perforin and these cells were, instead, skewed towards a
CD27+ profile in LNs (Fig 3D). We next employed tSNE analysis by merging single-cell CD4+ T
cell data together with matched blood and LN for an HIV+ CP with high levels of Tfh cells in LNs
and cytolytic CD4+ T cells in blood. Based on a set of memory and cytolytic markers, the tSNE
analysis confirmed a dissociation between effector and Tfh cells in the blood and LN. (Fig 3E).
Independent of HIV-infection status, these data together demonstrate an inherent lack of the
blood-like T-bethiEomes+ CD4+ T cell population, and thereby cytolytic cells, in LNs.

Paucity of effector CD4+ T cell responses in HIV-infected lymph nodes
Based on these premises, we next assessed the functional properties of CD4+ T cells following
stimulation with overlapping Gag and Env peptide stimulations. Paired blood and LN samples
from HIV+ CPs and ART+ subjects were collected for these assessments. We found higher frequencies of Gag-specific CD4+ T cells in LNs compared to blood for both CPs and ART+ subjects (Fig 4A). Additionally, the magnitude of the Env-specific CD4+ T cell response was only

PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006973 April 13, 2018

7 / 28

CD4+ T cell responses in HIV-infected lymph nodes

Fig 3. Phenotypic, cytolytic and transcriptional differences between LN and blood CD4+ T cells in HIV-infected and -uninfected individuals. (A)
Flow cytometry plots (HIV-infected CP) and scatter plots for naïve and memory subsets of LN and peripheral blood (PB) CD4+ T cells in HIV-infected and
-uninfected subjects. (B) Flow cytometry plots (HIV-infected CP) showing the lack of T-bethiEomes+ CD4+ T cells in LNs. Corresponding scatter plots
demonstrating the frequency of T-bethi cells of memory (non-naïve) CD4+ T cells (top) and frequency of Eomes+ cells of T-bethi CD4+ T cells (bottom) for
matched LN and PB. (C) Flow plots (HIV-infected CP) showing the lack of Granzyme B+perforin+ CD4+ T cells in LNs and scatter plots with the
frequency of LN and PB perforin+ cells of memory CD4+ T cells (top). Frequencies of Granzyme B+ cells of perforin+ CD4+ T cells (bottom) for matched
LN and PB. (D) Flow plots (HIV-infected CP) and scatter plots showing the distribution of CD27+ cells within the Granzyme B+ CD4+ T cell compartment
for matched LN and PB. (E) The distribution of different populations in the tSNE space is based on 30.000 live CD4+ T cells that were merged from LN and
PB from a HIV-infected CP with detectable levels of cytolytic cells in the PB and LN Tfh cells. The tSNE clustering is based on CD45RO, CD27, CCR7, T-
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bet, Eomes, Granzyme B, perforin, CXCR5 and PD-1 expression on gated bulk CD4+ T cells. The naïve cluster (green) is based on high CCR7 and low
CD45RO intensity; the Tfh cluster (red) on high intensity of PD-1 and CXCR5; and the effector cluster (orange) on high T-bet and perforin expression
intensity. After separating out the merged LN and PB single CD4+ T cell data, a lack of Tfh cells was apparent in PB and effector CD4+ T cells in the LN
(lower right tSNE plots). Median and IQR are shown for all scatter plots. Mann-Whitney tests were performed to compare differences between two
unmatched groups, and Wilcoxon matched-pairs single rank tests between matched samples;  P < 0.05,  P < 0.01 and  P < 0.001. All data-points are
derived from the North-American and Mexico cohort.
https://doi.org/10.1371/journal.ppat.1006973.g003

higher in LNs compared to blood for HIV CPs (Fig 4A). Although the LN CD4+ T cell
responses were higher compared to blood, LN Gag-specific CD4+ T cells tended to be dominated by either CD107α/TNF alone, or in combination, and less commonly produced IFNγ
(Fig 4B). In contrast to LN CD4 T cells, blood Gag-specific CD4+ T cells had more polyfunctional responses (Fig 4B). Likewise, SEB stimulated CD4+ T cells exhibited similar characteristics and showed an elevated polyfunctional repertoire in blood compared to LN (S8 Fig).
Next, we examined whether LN CD4+ T cells could upregulate perforin after stimulation as
a measure of their cytolytic potential [31, 32]. In general, few LN Gag-specific CD4+ T cells
upregulated perforin after peptide stimulation, whereas Gag-specific CD4+ T cells in the blood
expressed perforin to a higher degree (Fig 4C). The limitation of LN Gag-specific CD4+ T cells
to express perforin correlated with lower levels of T-bethi cells in LN compared to blood (Fig
4D). No difference between LN and blood was found in ART+ subjects for either perforin or
T-bethi cells suggesting that cytolytic Gag-specific CD4+ T cell responses are only present in
blood during viremic episodes.
We previously observed that β-chemokines are predominantly produced by the TbethiEomes+ population (Fig 2), suggesting that they may not be expressed by LN CD4+ T
cells given the general lack of high T-bet expression. We further explored this phenomenon on
SEB- and CMV-specific CD4+ T cells and found significantly lower frequencies of MIP-1α
+ SEB stimulated (Fig 4E) and CMV-specific (Fig 4F) CD4+ T cells in LNs compared to blood.
Notably, LN CMV-specific CD4+ T cells had poor co-expression of IFNγ and TNF in contrast
to their counterparts in blood (S9A Fig), indicating an inherent lack of multiple effector functions also by CMV-specific CD4+ T cells in LNs.

HIV elite controllers and acute seroconverters lack effector-like CD4+ T
cell responses in lymph nodes
HIV-1 elite controllers usually demonstrate a vigorous and highly polyfunctional effector
HIV-specific CD4+ T cell response in peripheral blood [3–6, 8]. We obtained LNs from a
cohort of HIV elite controllers (n = 9) and assessed whether those subjects had any evidence of
cytolytic CD4+ T cell activity in LNs. Most Gag-specific CD4+ T cells in blood from elite controllers tended to express moderate levels of T-bet but still showed an enrichment in the TbethiEomes+ subset compared to LN Gag-specific CD4+ T cells (Fig 5A). The majority of LN
HIV-specific CD4+ T cells were instead T-betdimEomes- (Fig 5A). In addition, the frequency
of perforin+ (Fig 5B) and MIP-1α+ (Fig 5C) Gag-specific CD4+ T cells in HIV elite controllers
was significantly higher in blood compared to LN. Similarly, we found very few perforin/Granzyme B+ CD4+ T cells in acute/early (Fiebig IV-VI) HIV seroconverter LNs (Fig 5D). Furthermore, early cycling (Ki-67+) CD4+ T cells, indicative of HIV-specific T cells [33, 34], in blood
showed tendencies of higher perforin, Granzyme B and T-bethi expression than LN Ki-67
+ CD4+ T cells in the acute/early HIV seroconverters (Fig 5D). Taken together, our data provide evidence of dissociated effector-like HIV-specific CD4+ T cell responses in LN compared
to blood suggesting spatial and temporal dissociated mechanisms of viral control in LNs of
HIV elite controllers and early HIV seroconverters.
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Fig 4. Functional characteristics of polyclonal and virus-specific effector CD4+ T cell responses in HIV-infected LNs and blood. (A) Flow cytometry
plots (HIV ART+ subject) and plots for matched HIV-Gag or–Env-specific CD4+ T cell responses in HIV-infected LN and PB. (B) Flow cytometry plots
(HIV-infected CP) showing the negative control (NC) and Gag-specific response of LN CD4+ T cell response. The high abundance of CD107a (red) that is
not co-expressed with IFNγ or TNF is illustrated in this example. SPICE analysis of functional combination between LN (red) and PB (red-gray) Gagspecific CD4+ T cell responses for HIV-infected CPs and ART+ subjects. (C) Flow plots (HIV-infected CP) of Gag-specific CD4+ T cell response (red)
from LN and PB in relation to CD27 and perforin expression. Graphs represent the frequency of (C) perforin+ and (D) T-bethi cells between LN and PB
Gag-specific CD4+ T cells. (E) Flow plots (HIV-infected CP) of MIP-1α versus IFNγ and TNF production for LN and PB SEB stimulated CD4+ T cells.
Corresponding plots showing the frequency of MIP-1α+ SEB stimulated CD4+ T cells (top) and MIP-1α+ of IFNγ/TNF/CD107a/MIP-1α+ SEB
stimulated CD4+ T cells (bottom). (F) Flow plots (HIV-infected CP) of MIP-1α versus IFNγ and TNF production for LN and PB CMV-specific CD4+ T
cells and corresponding graphs showing the frequency of MIP-1α+ CMV-specific CD4+ T cells (top) and MIP-1α+ of IFNγ/TNF/CD107a/MIP-1α
+ CMV-specific CD4+ T cells (bottom). Median and IQR are shown for all bar plots. Permutation test was performed between the pie charts. Wilcoxon

PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006973 April 13, 2018

10 / 28

CD4+ T cell responses in HIV-infected lymph nodes

matched-pairs single rank tests were performed to compare differences between two matched groups;  P < 0.05,  P < 0.01 and  P < 0.001. All datapoints are derived from the Mexico cohort.
https://doi.org/10.1371/journal.ppat.1006973.g004

Degranulating CD4+ T cells are functionally and transcriptionally distinct between
lymph nodes and blood. Although LN CD4+ T cells possess poor effector functions, we
could find degranulating (CD107a+) HIV- and SEB- stimulated CD4+ T cells at low levels in
LNs (Fig 4B). In line with previous studies [11], we found that blood CD107a+ SEB stimulated
CD4+ T cells were T-bethi. In contrast, degranulating LN SEB stimulated CD4+ T cells were
primarily T-betdim/- (S9B Fig). Surprisingly, many of the CD107a+ LN SEB stimulated CD4+
T cells expressed the B cell follicle homing receptor CXCR5, particularly in HIV-infected

Fig 5. Expression of effector molecules by Gag-specific CD4+ T cells from HIV elite controller LNs and blood. (A) Flow cytometry plots (HIV elite
controllers) illustrating the distribution of LN (red) and PB (blue) IFNγ+ Gag-specific CD4+ T cell responses between the T-betdimEomes- and TbethiEomes+ compartment. Corresponding scatterplots showing the frequencies of T-betdimEomes- (left) and T-bethiEomes+ (right) cells of Gag-specific
CD4+ T cells between LN and PB for HIV elite controllers. Flow plots (HIV elite controllers) of IFNγ+ Gag-specific CD4+ T cell response from LN and PB
in relation to (B) perforin and (C) MIP-1α expression. Graphs represent the frequency of (B) perforin+ and (C) MIP-1α+ Gag-specific CD4+ T cells
between LN and PB. (D) Flow plots and graphs demonstrating the expression pattern of perforin+Granzyme B+ memory CD4+ T cells in acute/early
seroconverters (left graph). Right graphs show the frequency perforin+Granzyme B+ or T-bet expression out of total memory Ki-67+ CD4+ T cells.
Median and IQR are shown for all scatter plots. Mann-Whitney tests were performed to compare differences between groups;  P < 0.05,  P < 0.01 and

P < 0.001. All data-points are derived from the North-American cohort.
https://doi.org/10.1371/journal.ppat.1006973.g005
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subjects (Fig 6A). Interestingly, in the HIV-infected subjects, degranulating SEB stimulated
CD4+ T cells were also CXCR5hi and these cells were as frequent as CXCR5- cells (Fig 6A). In
contrast, blood CD107a+ SEB stimulated CD4+ T cells were primarily CXCR5- in all groups
assessed (Fig 6A).
We further explored CXCR5 expression on degranulating HIV-specific CD4+ T cells and
found that a majority of the LN CD107a+ Gag-specific CD4+ T cells were either CXCR5+ or
CXCR5hi (Fig 6B) and had minimal perforin expression independent of ART status (Fig 6C).
Blood CD107a+ Gag-specific CD4+ T cells were instead mostly CXCR5- and demonstrated
some perforin expression (Fig 6C). Furthermore, analysis on IFNγ/CD107a/TNF-producing
Gag-specific CD4+ T cells confirmed similar characteristics, indicating that HIV-specific CD4
+ T cells in LNs are highly skewed towards a CXCR5+ or CXCR5hi phenotype (S9C Fig).
We also determined the transcriptional and functional signature of CD4+ T cells from LN
and peripheral blood degranulating in response to SEB, through single-cell Biomark geneexpression analysis. Similar to before [35], we developed a Biomark panel to assess the gene
expression levels of specific CD4+ T cell functions, transcription factors, signaling molecules,
chemokine receptors, inhibitory and co-stimulatory receptors, and caspases. tSNE analysis,
based on all assessed markers that reached a single-cell average LOD >1.5 cut-off (n = 71) (S10
Fig), demonstrated that LN CD107a+ cells formed a separate single-cell cluster compared to
blood CD107a+ cells (Fig 6D). Additional analysis of individual genes demonstrated that LN
CD107a+ cells had higher expression of Tfh-related genes [36], including cxcr5, ascl2, tox,
tox2, ctla4, btla, and ox40. Instead, CD107a+ cells from blood demonstrated significantly
higher transcript levels of Th1/cytolytic gene profiles [36, 37], such as ifng, prf1, xcl1, ccl3, ccl4,
ccl5, bcl2l11, prdm1, and stat4 (Fig 6D).

LN CD4+ T cells form poorly organized synaptic interfaces and exhibit
delayed granule release
Cytolytic T cell activity requires granule release through a stable immunological synapse [38].
As such, we directly visualized the structure of CD4+ T cell immunological synapses formed
by degranulating LN and blood CD4+ T cells in real time by exposing CD4+ T cells to planar
lipid bilayers containing fluorescently labelled soluble ICAM-1 and -CD3 antibodies. In order
to maximize the vertical resolution at the T cell/bilayer interface, we used total internal reflection fluorescence (TIRF) microscopy to examine the structure of the T cell contact surface and
the appearance of CD107a in real time [39–41]. Analysis of LN and blood CD4+ T cells isolated from either chronically HIV-infected or uninfected individuals revealed four different
groups of synapse formation: CD4+ T cells capable of establishing mature cytolytic synapses,
but do or do not release granules, CD4+ T cells able to release granules without establishing
cytolytic synapses, and, finally, CD4+ T cells that neither form the synapses nor release granules (Fig 7A). CD4+ T cells from both blood and LN of chronically infected individuals contained a considerable fraction of cells that are capable of releasing granules without formation
of mature synapses. However, the fraction of blood CD4+ T cells demonstrating both synapse
formation and granule release was considerably larger than for LN CD4+ T cells in HIVinfected individuals (Fig 7B). Furthermore, the difference between LN and blood CD4+ T cells
in the kinetics of granule release, a parameter linked to the efficiency of T cell cytolytic activity
[42], was even more striking. Regardless of the infection status, blood-derived CD4+ T cells
were able to release granules almost twice as fast as LN-derived CD4+ T cells (Fig 7C and 7D).
Not surprisingly, the HIV-specific CD4+ T cell clone AC25 showed superior ability to establish
mature immunological synapse and rapid degranulation (Fig 7A–7D). Altogether, these data
suggest that while some LN CD4+ T cells are able to degranulate, few have the necessary
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Fig 6. Functional and transcriptional differences between degranulating cells in LN and blood. (A) Flow cytometry plots (HIV-uninfected subject) of
matched LN and PB CD107a+ SEB stimulated CD4+ T cell responses. Graphs are showing the frequencies of LN (top) and PB (bottom) CD107a+ SEB
stimulated CD4+ T cell responses for CXCR5-, CXCR5+ and CXCR5hi cells. (B) Flow plots (HIV-infected CP) illustrating the expression of CD107a+
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(red) Gag-specific CD4+ T cells in relation to CXCR5 between LN (top) and PB (bottom). (C) Corresponding plots from the same subject showing the
expression of CD107a+ (red) Gag-specific CD4+ T cells in relation to CXCR5 and perforin for LN (top) and PB (bottom). Graphs represent the frequency
of CD107a+ cells within the CXCR5+, CXCR5hi and perforin+ compartment for LN (top) and PB (bottom) Gag-specific CD4+ T cells. (D) Biomark
analysis illustrating the tSNE distribution of single SEB stimulated CD107+ CD4+ T cells from LN (black) and PB (gray). Individual graphs represent the
relative Log2 expression of different markers being significantly different (P<0.05) between blood and LN CD107+ cells. Non-parametric Kruskal Wallis
test with Dunn’s multiple comparison test was performed to determine significant differences between groups;  P < 0.05,  P < 0.01 and  P < 0.001. All
data-points are derived from the North-American and Mexico cohort.
https://doi.org/10.1371/journal.ppat.1006973.g006

functional qualities to launch an efficient antiviral effector response at the significant site of
HIV replication.

Discussion
The progressive decline of memory CD4+ T cells is a general hallmark of chronic HIV disease
in most individuals. Accumulating evidence suggests that HIV-specific CD4+ T cells play an
important role in host defense mechanisms against the virus. Late stage maturation and
increased effector functions, including β-chemokine production and cytolytic activity, by
peripheral blood CD4+ T cells have been linked to a lower degree of viral susceptibility and
slower disease progression in HIV-infected individuals [9–18]. However, whether CD4+ T
cells derived from lymphoid tissues from HIV-infected individuals possess such effector functions has heretofore remained unclear. Indeed, lymphoid tissues are known from studies on
HIV-uninfected subjects to harbor CD4+ T cells with entirely different plasticity and functional characteristics than CD4+ T cells in blood [43, 44]. In this study, we demonstrate that
CD4+ T cells expressing high levels of T-bet and Eomes represent the major producers of classical T cell effector functions, such as cytolytic molecules and β-chemokines. However, this
effector CD4+ T cell subset is rare in HIV-infected or -uninfected LNs; a finding similar to
that recently described for CD8+ T cells [32]. Importantly, HIV elite controllers also have
lower frequencies in vivo effector CD4+ T cell responses in LNs during chronic disease, implicating a spatial or temporal displacement in maintaining control of HIV replication in LNs.
Together these results indicate that effector CD4+ T cells are unlikely to play a major direct
role in control of HIV replication within lymphoid tissue.
Synergy between the transcription factors T-bet and Eomes has been intensively studied
in the context of effector CD8+ T cell differentiation, and studies have suggested that the
interplay between T-bet and Eomes in CD4+ T cell differentiation drives the cytolytic CD4
T cell program [11]. T-bet was originally defined as the master regulator of CD4+ T cell Th1
polarization and expression of effector cytokines such as IFNγ and TNF [21]. Eomes is also
expressed in CD4+ T cells, where it can compensate for loss of T-bet to retain IFNγ production and thereby Th1 polarization [22]. Recent studies have implicated that Eomes is particularly important for driving cytolytic CD4+ T cell responses in vivo [45]. In addition, other
transcription factors, such as ThPok, have been associated with cytolytic CD4+ T cell activity in mice [26]. Similar to our previous observations in CD8+ T cells [23, 46], we found a
very strong correlation between high expression levels of T-bet and perforin within Eomes+
peripheral blood human CD4+ T cells. However, Eomes+T-betdim/- CD4+ T cells had low
perforin expression and poor β-chemokine production, indicating that Eomes alone is not
sufficient to maintain effector functions in human CD4+ T cells. Together these data suggest that CD4+ T cells with high levels of T-bet are the preeminent producers of cytolytic
molecules and β-chemokines, representing a multifunctional effector CD4+ T cell population in human blood.
Increased frequencies of cytolytic CD4+ T cells have been described previously in the context of HIV infection [10], but it remains unknown to what degree they are preserved.

PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006973 April 13, 2018

14 / 28

CD4+ T cell responses in HIV-infected lymph nodes

Fig 7. Synaptic interface, degranulation pattern and kinetics of degranulation by LN and blood CD4+ T cells. Freshly isolated CD4+ T cells were
exposed to planar lipid bilayers containing fluorescent labeled ICAM-1 and anti-CD3 antibodies and the structure of the T cell/bilayer interface and pattern
and kinetics of degranulation were analyzed by TIRF microscopy. (A) Representative images of T cell/bilayer interface demonstrating patterns of
accumulation and segregation of TCR and integrin molecules and the appearance of CD107a proteins at the interface are shown. The cells fall into 4
different groups: 1) T cells demonstrating the formation of classical cytolytic synapse containing central (cSMAC) domain, peripheral ring junction
(pSMAC), and centrally located CD107a indicating granule release (solid red); 2) T cells showing the formation of cytolytic synapse without detectable
granule release (solid blue); 3) T cells that are characterized by aggregation of TCR and integrin molecules without formation of mature cytolytic synapse,
but with detectable granule release (red stripes); 4) T cells that display overlapping aggregates of TCR and integrin molecules without granule release (blue
stripes). (B) Diagrams showing representation of LN- and PB-derived T cells of HIV-infected ART- and uninfected individuals with different structure of
synaptic interfaces and patterns of granule release displayed in panel (A); HIV-specific cloned CD4+ T cells AC25 are shown for comparison reasons. (C)
Time-dependent changes of the structure of T cell/bilayer interfaces and appearance of the released granules for representative T cells derived from LN and
PB are shown. (D) Quantitation of the kinetics of granule release by LN (closed circles) and PB (open circles) CD4+ T cells isolated from HIV-infected ART(red circles) and uninfected (black circles) individuals. The kinetics of granule release by HIV-specific T-cell clone AC25 is shown for comparison reasons
(depicted by open blue circles). Each individual circle designates first appearance of detectable granule release by individual cells. Median and IQR are
shown for all scatter plots. Mann-Whitney tests were performed to compare differences between indicated groups of T cells;  P < 0.05,  P < 0.01.
https://doi.org/10.1371/journal.ppat.1006973.g007

Through access to cohorts with time points from before and after HIV infection we now show
that the frequencies of effector CD4+ T cells increase longitudinally after HIV infection and that
in peripheral blood these cells are not depleted during chronic HIV infection. The reason for

PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006973 April 13, 2018

15 / 28

CD4+ T cell responses in HIV-infected lymph nodes

their preservation is probably multifaceted, but our data revealed that T-bethiEomes+ CD4+ T
cells were less susceptible to in vitro HIV infection compared to conventional CD45RO+ CD4+
T cells, potentially due to autocrine β-chemokine production [15]. Another explanation however
could simply be that effector CD4+ T cells are preserved during HIV infection because they are
not present in lymphoid tissues where the vast majority of viral replication takes place [24]. Most
T cells have been thought to recirculate between blood and lymphoid or non-lymphoid tissues
[47, 48], but recent human data on multiple organs implicate that terminally-differentiated
(effector) CD4+ T cells are primarily present in peripheral blood and highly-vascularized tissues
[44, 49]. Our data support these previous studies on human organ donors, demonstrating that
few CD27- terminally-differentiated CD4+ T cells are present in LNs, independent of HIV infection. As such, it remains possible that CD4+ T cell tissue compartmentalization and trafficking
properties of unique subsets could partly explain why certain CD4+ T cells are depleted or preserved during acute and chronic HIV disease.
Peripheral blood only contains 2% of the total number of lymphocytes, where a predominant fraction resides in lymphoid tissues [50, 51]. However, most of our understanding on
CD4+ T cell function, phenotype, and transcriptional characteristics in HIV infection comes
from peripheral blood T cells. Knowledge of LN CD4+ T cell responses against HIV is limited,
despite the fact that lymphoid tissues serve as key sites for the dissemination and long-term
maintenance of HIV replication and the viral reservoir [52]. Previous studies have established
that CD8+ T cells in HIV-infected LNs generally express low-levels of cytolytic molecules [53,
54], but similar studies have not been conducted on effector LN CD4+ T cells. While CD8+ T
cells seem to express some effector molecules in HIV-infected LNs [32], we found few TbethiEomes+ CD4+ T cells, which is associated with minimal expression of cytolytic molecules,
β-chemokines and IFNγ. The presence of cytolytic Gag-specific CD4+ T cell responses was
only present in viremic subjects, which indicates that ongoing viral replication is necessary to
maintain the presence of cytolytic CD4+ T cells against HIV in blood. Furthermore, we also
identify that LN CD4+ T cells form impaired immunological synapses and release cytolytic
granules with slower kinetics, consistent with inefficient potency of target cell destruction.
HIV-specific CD4+ T cells were frequently present in LNs; however, these responses appeared
to be monofunctional for TNF production or CD107a upregulation and less expression of
IFNγ. The lack of β-chemokine production in LNs is of particular interest as several studies
have proposed that such functional properties provide resistance to HIV infection [15, 16].
Autocrine β-chemokine production by CD4+ T cells could still be a protective mechanism
prohibiting productive infection by HIV in peripheral blood, but likely not in LNs.
The magnitude of HIV-specific CD4+ T cell responses was highest in blood during peakviremia and coincided with increased T-bet, perforin and MIP-1α production. In contrast,
very few cytolytic CD4+ T cells were present in LNs during acute/early HIV infection. Notably,
previous studies have shown that LN T cells egress from tissues to enter the blood stream after
the acquisition of cytolytic activity [55]. Despite the finding that LCMV-specific LN CD8+ T
cells can degranulate during acute infection, they do kill target cells less efficiently [55]. This
notion is also in line with our chronic HIV data, showing a disassociation between LN and
blood for different subsets of CD4+ T cells that can degranulate. LN CD4+ T cells can degranulate, but these cells express low levels of cytolytic markers and form impaired immunological synapses. Instead they seem to be skewed towards a CXCR5+ phenotype, suggesting that
unique Tfh-subsets degranulate and may secrete factors of unknown nature. Future studies
should clarify the role and content of granules in LN CD4+ T cells, as such responses seem to
be differently regulated and not contain cytolytic molecules or β-chemokines.
Numerous studies have identified that HIV elite controllers possess CD4+ T cell responses
with higher polyfunctionality, Gag specificity, proliferative capacity, cytolytic activity and β-
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chemokine production [4, 5, 8, 9, 18, 56]. Surprisingly, we found a distinct dissociation of
effector CD4+ T cell responses in LNs compared to PB in HIV elite controllers. The higher
abundance of effector CD4+ T cell responses in peripheral blood could suggest that such
responses, together with other factors, are maintaining control in the blood circulation, but
not in lymphoid tissues. Furthermore, previous studies have established that HIV-specific
CD4+ T cells are generating pressure on the virus, based on the fact that escape mutations
emerge within MHC-II-restricted epitope regions [57–59]. Given the limited expression of
cytolytic molecules for both HIV-specific CD4+ and CD8+ T cells in LNs [32], it remains possible that non-cytolytic factors are involved in control mechanisms of HIV and could generate
viral escape mutants in LNs [60]. Indeed, elegant studies combining CD8+ T cell depletion
and ART to study the lifespan of SIV-infected cells longitudinally found that depletion of
CD8+ T cells had minimal effect on the death rate of virus infected cells, indicating that CD8+
T cells must act via other mechanisms than direct lysis of cells [61, 62]. Similar studies have also
demonstrated that the death-rate of cells infected with wild type and escape mutant viruses are
not different, indicating that non-cytolytic functions can drive viral escape and is associated
with control of lentiviruses [63]. Modeling of escape has also shown that non-cytolytic functions
can select for escape variants, although more slowly than cytolytic responses [64]. Further studies should clarify if cell antiviral functions [65] produced by HIV-specific T cells can generate
selective pressure on the virus and lead to elite control of HIV in lymphoid tissues.
In conclusion, we have determined that CD4+ T cells with elevated levels of T-bet and
Eomes represent a pleiotropic effector population that is present and preserved in HIVinfected blood. This unique CD4+ T cell population is however almost excluded from HIVinfected LNs. As a consequence, LN CD4+ T cells generally possess lower effector functions,
independent of HIV disease status or infection. Our data provide evidence of lack of association between effector-like HIV-specific CD4+ T cell responses in LNs and blood, suggesting
dissociated mechanisms of viral control in LNs.

Materials and methods
Ethical statement
Written informed consent was obtained from all study participants and blood samples were
acquired with institutional review board approval at each collecting institution: University of
Pennsylvania (IRB#809316, IRB# 815056), Human Subjects Protection Branch (RV217/
WRAIR#1373), The United Republic of Tanzania Ministry of Health and Social Welfare
(MRH/R.10/18/VOLL.VI/85), Tanzanian National Institute for Medical Research (NIMR/HQ/
R.8aVol.1/2013), Royal Thai Army Medical Department (IRBRTA 1810/2558), Uganda
National Council for Science and Technology–National HIV/AIDS Research Committee (ARC
084), Uganda National Council of Science and Technology (HS 688), The Swedish Regional
Ethical Council (Stockholm, Sweden 2009/1485-31, 2013/1944-31/4, 2014/920-32, 2012/999-32
and 2009/1592-32), INER-CIENI Ethics Committee and the Federal Commission for the Protection against Sanitary Risk (COFEPRIS), the Institutional Review Boards of the Case Western
Reserve University (CWRU) and Cleveland Clinic Foundation (CCF). All human subjects were
adults. This study was conducted in accordance with the Declaration of Helsinki.

Samples
Mesenteric, iliac, inguinal and cervical lymph node (LN) biopsies and peripheral blood were
collected from individuals classified as HIV−(n = 51), HIV+ chronic and naïve to ART
(n = 71), HIV+ chronic on ART (n = 25), HIV+ elite controllers (n = 18), and HIV+ acute/early
seroconverters (n = 17). Recruitment occurred at six sites: University of Pennsylvania (Penn)
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(HIV−blood and iliac LNs; HIV+ ART+/ART−blood and matched iliac LNs); INER-CIENI in
Mexico City (HIV+ ART+/ART−blood and matched cervical LNs); Case Western Reserve University (HIV−mesenteric LNs); University of California, San Francisco (UCSF) (HIV+ EC
inguinal LNs); Karolinska Instituet (HIV−and HIV+ ART+/ART−blood) and the RV217 early
capture HIV cohort (longitudinal HIV−and HIV+ ART−blood samples). Subject grouping, tissue types, and clinical parameters are summarized in S1 Table. All clinical characteristics of
the RV217 cohort has been described previously [66]. HIV−LN samples were obtained from
following procedures/conditions: mesenteric LNs (patients undergoing abdominal surgery)
and iliac LNs (kidney transplant donors). Sample size was based on the availability of biological samples rather than a pre-specified effect size and was not blinded to the persons executing
experiments.

Specimens
Peripheral blood mononuclear cells (PBMCs) were collected from whole blood or leukapheresis products using Ficoll-Hypaque (GE Healthcare) density gradient centrifugation. Lymph
node mononuclear cells (LNMCs) were isolated by manual disruption or using a gentleMACS
tissue dissociator. PBMCs and LNMCs were cryopreserved and stored at -140˚C for further
usage in all experiments.

Flow cytometry (FACS)
For all experiments, human cryopreserved PBMCs and LNMCs were thawed and rested for at
least 1 hour in complete media (R10), containing RPMI-1640 media supplemented with 10%
FBS, 1% L-glutamine, and 1% penicillin/streptomycin. Cells were then washed with PBS, prestained for chemokine receptors/ adhesion molecules at 37˚C for 10 minutes, stained with
LIVE/DEAD Aqua (Invitrogen) for 10 minutes, and surface stained with an optimized antibody cocktail for 20 further minutes. Cells were then washed with FACS buffer (PBS containing 0.1% sodium azide and 1% BSA), fixed, and permeabilized using the Cytofix/Cytoperm
Buffer Kit (BD Biosciences) or the FoxP3 Transcription Factor Buffer Kit (eBioscience). An
optimized antibody cocktail was then added for 1 hour to detect intracellular/-nuclear markers. Cells were fixed in PBS containing 1% paraformaldehyde (Sigma-Aldrich) and stored at
4˚C. All samples were acquired within 3 days using an LSRII (BD Biosciences) and data was
analyzed with FlowJo software (version 9.8.8 or higher, TreeStar).
For stimulations, cells were stimulated with 5 μg/mL Brefeldin A (Sigma Aldrich), and
overlapping HIV Gag-p55 (NIH), HCMV IE1/pp65 peptides (NIH), SEB (Sigma Aldrich),
α-CD3 (BioRad) and α-CD28/CD49d (BD) or medium alone (negative controls). When antiCD107a was added at the start of the stimulation protocol [67], monensin (0.7 μg/mL, BD Bioscience) was also supplemented.
For sorting experiments, PBMCs and LNMCs were thawed and rested overnight. Cells
were next day stained in 15-mL conical tubes following the procedure described above with
higher concentrations of antibodies (i.e. not diluted 1:50 in FACS buffer). Cells were then
washed with PBS and suspended in R10 media. Sorting was carried out using a FACSAriaII
(BD Biosciences) instrument.

Flow antibodies
The following antibodies were used for human FACS experiments: α-CCR7 APC-Cy7 or
BV711 (clone G043H7, BioLegend), α-CD14 BV510 or V500 (clone M5E2, BioLegend), αCD14 PE-Cy5 (clone 61D3, Abcam), α-CD19 BV510, V500 or PE-Cy5 (clone HIB19, BioLegend), α-CD3 BV570, AF700, APC-H7, APC-Cy7 or APC-R700 (clone UCHT1, BD
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Biosciences), α-CD4 PeCy5.5 (clone S3.5, Invitrogen), α-CD8a BV570, BV605, or BV711
(clone RPA-T8, BioLegend), α-CD27 BV650 or BV785 (clone O323, BioLegend), α-CD45RO
BV650 or PE-CF594 (clone UCHL1, BD Biosciences), α-CD45RO ECD (clone UCHL1, Beckman Coulter), α-CXCR5 AF488 or AF647 (clone RF8B2, BD Biosciences), α-CXCR5 PE-Cy7
(clone J252D4, BioLegend), α-PD-1 APC-Cy7 or BV421 (clone EH12.2H7, BioLegend), αHLA-DR BV605 or BV650 (clone G46-6, BD Biosciences), α-CD38 APC or BV711 (clone
HIT2, BioLegend), α-IFNγ FITC or AF700 (clone B27, Invitrogen), α-TNF PE-Cy7 or BV605
(clone MAb11, BD Biosciences), α-CD107a PE-Cy5 or PE-Cy7 (clone H4A3, eBioscience), αMIP-Iα FITC (clone MAB271, R&D Systems), α-MIP-Iβ PE-Cy7 or PE (clone D21-1351 BD),
α-perforin BV421 or PE-Cy7 (clone B-D48, BioLegend), α-granzyme B Alexa700 (clone GB11,
BD Biosciences), α-T-bet PE (clone 4B10, eBioscience), α-T-bet PE-Dazzle 594 or FITC (clone
4B10, BioLegend), α-Eomes AF647 or EF660 (clone WD1928, eBioscience), and α-Ki67 FITC
(clone B56, BD Biosciences). LIVE/DEAD Aqua (Invitrogen) or DAPI was used to discriminate dead cells.

Single-cell gene expression analysis
PBMCs and LNMCs from HIV–uninfected subjects (n = 2) were thawed, rested overnight and
stained as described above. SEB stimulated CD107+ CD4+ T cells were single-cell index sorted
into individual wells of a 96-well PCR plate according to the gating strategy depicted in S10A
Fig. Each well contained 5 μL lysing buffer, consisting of 4.725 μL of DNA Suspension Buffer
(10 mM Tris, pH 8.0, 0.1 mM EDTA; TEKnova), 0.025 μL of 20 U/μL SUPERase (Ambion)
and 0.25 μL of 10% NP40 (Thermo Scientific). After FACS sorting, PCR plates were frozen
and kept in -80˚C until usage.
Similar to before [35], PCR plates were thawed and pre-heated for 90 seconds at 65˚C.
Reverse Transcription Master Mix (Fluidigm) was added to each well and plate was placed
into a thermocycler for reverse transcription (25˚C for 5 min, 42˚C for 30 min, 85˚C for 5
min). Next, pre-amplification mix, consisting of pooled mixture of all primer assays (500nM),
5× PreAmp Master Mix (Fluidigm) and H2O, was added to each well and run on a thermocycler (95˚C for 5 min followed by 18 cycles: 96˚C for 5 sec 60˚C for 6 min). Exonuclease mixture, containing of Exonuclease I (New England BioLabs), 10× Exonuclease I Reaction Buffer
(New England BioLabs) and H2O was added to each well to remove excessive primers and the
plate was run on a thermocycler (37˚C for 30 min, 80˚C for 15 min). Each well was diluted
(1:4) with DNA Suspension Buffer (10 mM Tris, pH 8.0, 0.1 mM EDTA; TEKnova). Distinct
primer assays were generated by adding individual primer pairs (5μM) together with a mix of
2x Assay Loading Reagent (Fluidigm) and 1x DNA suspension buffer to each well of a new
plate. A “sample PCR plate” was created by dispensing a sample master mix, containing 2x Sso
Fast EvaGreen Supermix with Low ROX (Bio-Rad), 20x DNA Binding Dye Sample Loading
Reagent (Fluidigm) and H2O to each well. Pre-amplified samples were added to each well of
the sample PCR plate. Control line fluid (Fluidigm) was injected to the 96.96 Dynamic Array
chip (Fluidigm) and the chip was primed using an IFX Controller HX. After priming the chip,
primer assays and sample mix was added to the unique detector inlets of the chip and transferred to the IFX Controller HX for loading the mixtures. The chip was then transferred to a
Biomark HD instrument (Fluidigm) and run using the GE Fast 96x96 PCR+Melt v2.pcl program. All primers were purchased from IDT and assay efficiency as well as melting and amplification curves for each assay were evaluated beforehand on separate Biomark HD runs and
using qPCR.
All data were pre-analyzed with the Real-time PCR analysis software (Fluidigm), and Linear
(Derivative) and User (Detectors) were used as settings to generate Ct values. A Ct value of 25
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was used as limit of detection (LOD). The relative gene expression was defined as a log2 value
using the formula: log2 = LOD–Ct. All downstream analysis of the gene expression data,
including tSNE analysis, were performed using R Studio or Graph Pad Prism v7.0
(GraphPad).

Isolation of CD4+ T cells for image analysis
Frozen PBMCs or LNMCs of uninfected or HIV-infected individuals (n = 2) were thawed and
incubated overnight in complete media (RPMI supplemented with 10% of fetal bovine serum,
penicillin/streptomycin and glutamine) at 37˚C. CD4+ T cells were then purified by negative
immunomagnetic sorting using MACS technology CD4+ T cell purification kit according to
the manufacturer’s instructions. The cells were transferred into the assay buffer (20 mM
HEPES, pH 7.4, 137 mM NaCl, 2 mM Na2HPO4, 5 mM D-glucose, 5 mM KCl, 1 mM MgCl2, 2
mM CaCl2, and 1% human serum albumin) and kept at +4˚C (1–2 hours) prior to the analysis.
The human HIV-specific CD4+CTL clone AC-25 that recognizes PEVIPMFSALSEGATP
(PP16) peptide from HIV Gag protein was used as a positive control [39, 68].

Planar lipid bilayers preparation
1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt) (Biotinyl cap
PE), 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic
acid)succinyl] (nickel salt) (NiNTA-DOGS) and 1,2-dioleoyl-sn-glycero-3-phosphocholine
(DOPC) lipids were supplied by Avanti Polar Lipids. Planar lipid bilayers were prepared as
previously described [39–41, 69]. Liposomes that contained biotinyl-CAP functionalized lipids
(Avanti Polar Lipids) at 4 mol% and liposomes containing NiNTA-DOGS lipids at 35 mol%
were used to prepare bilayers. The final concentrations of biotinyl-CAP and NiNTA-DOGS in
the bilayers were 0.01 mol% and 17.5 mol%, respectively. Streptavidin (2 μg/ml) and monobiotinylated anti-CD3 (OKT3) monoclonal antibody labeled with Alexa Fluor 488 (2 μg/ml) were
reacted sequentially with the biotinylated bilayers to produce the antibody density of 50 molecules/μm2. Cy5-ICAM-1-His6 molecules were incorporated into the bilayers at the density 300
molecules/μm2. Densities of Cy5-ICAM-1 and anti-CD3 antibody on the bilayers were determined as described elsewhere [70].

TIRF microscopy
TIRF images were acquired with an Andor Revolution XD system equipped with Nikon
TIRF-E illuminator, 100/1.49 NA objective, Andor iXon X3 EM-CCD camera, objective
heater, and a piezoelectric motorized stage with Perfect Focus. The cells were combined with
Alexa 568-labeled anti-CD107a antibody Fab fragments at a final concentration of 4 μg/ml and
injected into the channel of ibidi slides containing a lipid bilayer. The images of the bilayers
were then recorded for 30 minutes at a rate of one image per minute. The resulting images
were analyzed using the MetaMorph imaging suite.

Image analysis
To determine the parameters of cell-bilayer interactions we chose only CD4+ T cells productively interacting with the bilayers. That was determined by accumulation of anti-CD3 antibodies at the interface and confirmed by morphology analysis of the cells observed in the
transmitted light images. Clustered cells and visibly damaged or apoptotic cells were excluded
from analysis.
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The efficiency of ICAM-1accumulation for selected cells was measured by determining the
average fluorescence intensity of accumulated Cy5-labeled ICAM-1 molecules at the cellbilayer interface over background fluorescence outside of the contact area in close proximity
to the cell. Cell was discerned to accumulate ICAM-1, if the signal-to-background ratio was at
least 1.3. If accumulated ICAM-1 molecules formed a ring structure that was observed on at
least two consecutive images, we determined that the cell was developing pSMAC. The granule
release was evaluated by measuring the average fluorescence intensity of accumulated Alexa
568-labeled anti-CD107a antibody Fab fragment at the T cell/bilayer interface over the background outside the contact area but in close proximity to the cell. Cells with the ratio of Alexa
568 signal to background of at least 1.3 were designated as degranulating cells. All analyzed
cells demonstrated one of the following four degranulation patterns: forming or not forming a
pSMAC and degranulating or not at the same time. For every sample, we determined the fractions of the total cells corresponding to each pattern of degranulation. To quantify the kinetics
of granule release at cell-bilayer interface for all of the degranulating cells, we determined the
earliest time point when degranulation was observed.

Imagestream analysis
For imaging flow cytometry, human PBMC were stained with DAPI (5 ug/mL) for 5 min and
100,000 events were imaged on an ImageStreamX (Amnis Corp). Images were captured using
a 60x lens with an extended depth of field option using Inspire software (Amnis Corp). Antibody capture beads (BD Biosciences) were used as individual compensation tubes for each
fluorophore. Masking functions within IDEAS 5.0 were used to define nuclear and cytoplasmic T-bet and Eomes as previously described [25].

HIV infection assay
DHIV3 plasmid was provided by Dr. Edward Barker [71] (Rush University, Chicago, IL).
VSV-G pseudotyped viruses were produced as previously described [72]. PBMCs were stimulated with SEB for 3 days before addition of the pseudotyped virus. Gag-p24 (clone KC57,
Beckman Coulter) expression was determined by flow cytometry on day 5 post-infection.

Statistical analysis
Mann-Whitney or unpaired t-tests were used to compare differences between unmatched
groups, and Wilcoxon matched-pairs single rank or paired t-tests were used to compare differences between matched samples. Spearman or Pearson tests were used for correlation analyses.
Non-parametric or parametric tests were conducted based on normal distribution of the data
points (Shapiro-Wilk normality test). All analyses were performed using R studio, Graph Pad
Prism v7.0 (GraphPad). FlowJo and Cell ACCENSE (Automatic Classification of Cellular
Expression by Nonlinear Stochastic Embedding) analyses were used to conduct multivariate
tSNE analysis on the single-cell flow data sets [73].

Supporting information
S1 Table. Characteristics of study subjects.
(PDF)
S1 Fig. Transcription factor expression in CD4+/CD8+ T cells and cytolytic CD4+ T cells.
(A) Flow histograms showing expression of ThPOK and Runx3 expression in CD4+ T cells
(red) and CD8+ T cells (blue). (B) Histograms demonstrating ThPOK, Runx3, Eomes and T-
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bet expression in non-cytolytic (blue) and cytolytic (red) CD4+ T cells.
(PDF)
S2 Fig. T-bet and Eomes co-expression patterns within naïve and memory CD4+ T cell
compartments. Flow plot (left) and scatter plots (right) showing the frequency of T-bet and
Eomes expressing populations within naïve (CCR7+CD27+CD45RO-), transitional memory
(TM; CCR7-CD27+CD45RO+), effector memory (EM; CCR7-CD27-CD45RO+) and terminally-differentiated (TD; CCR7-CD27-CD45RO-) CD4+ T cells.
(PDF)
S3 Fig. β-chemokines are primarily produced by CD4+ T cells expressing high levels of Tbet. (A) Representative flow plot showing the co-expression between MIP-1α and MIP-1β for
SEB stimulated CD4+ T cells. (B) Co-expression pattern for T-bet versus MIP-1α, MIP-1β,
and IFNγ by SEB stimulated (top) and CMV-specific (bottom) CD4+ T cells. Frequencies of
MIP-1α/β+ for T-bethi, T-betdim and T-bet- CD4+ T cells following SEB- and CMV-pp65 stimulations. (C) Expression of MIP-1α and IFNγ by negative control (NC), CMV-specific and αCD3-CD28-specific CD4+ T cells in a donor with a T-bethiEomes+ population (top) versus a
subject with no such population (bottom). Non-parametric Kruskal Wallis test with Dunn’s
multiple comparison test was conducted to compare differences between groups;  P < 0.01
and  P < 0.001.
(PDF)
S4 Fig. T-bethiEomes+ CD4+ T cells are not productively infected by HIV. (A) Representative flow plots demonstrating Gag-p24 detection in CD25+ and CD45RO+ CD4+ T cells activated for 3 days with SEB. (B) Flow plot (left) and before-after graph (right) of Gag-p24+ cells
within the Eomes+ compartment. A Wilcoxon test was performed to compare the difference
between groups;  P < 0.001.
(PDF)
S5 Fig. T-bethiEomes+ CD4+ T cell counts are not impacted by ART. (A) The impact of
ART over time on the frequency of T-bethi (red) and Eomes+ (blue) CD4+ T cells is (B) associated with a redistribution of naïve CD4+ T cells.  in Fig A annotates differences between different time-points after and before ART (week 0). Absolute counts of T-bethi (red) and Eomes
+ (blue) CD4+ T cells are not impacted by ART both during (C) short-term and (D) longterm ART. A non-parametric Spearman test was used for the correlation analysis. Wilcoxon
tests were performed to compare differences before and after ART. Non-parametric Kruskal
Wallis test was conducted to compare differences at multiple time-points before and after
ART. Median and IQR are shown for all groups.  P < 0.05;  P < 0.01 and  P < 0.001.
(PDF)
S6 Fig. Dynamics of IFNg+ HIV-specific CD4+ T cell responses following HIV infection.
IFNγ+ Gag-specific CD4+ T cells before and subsequently following HIV infection. The colored lines represent each subject and their absolute frequencies over time.
(PDF)
S7 Fig. Gating scheme, Tfh correlations and comparison of CD4+ and CD8+ T cell expression of cytolytic molecules. (A) Representative gating scheme of blood (top) and LN (bottom)
CD4+ T cells from the same HIV+ subject. (B) Flow plots (left and middle) demonstrating the
expansion of Tfh cells in an HIV-infected CP and the corresponding TM phenotype (middle).
The non-parametric Spearman correlation plot demonstrate that increased frequencies of TM
cells are associated the expanded pool of Tfh cells in HIV-infected LNs. (C) Frequency of perforin expression on memory CD4+ and CD8+ T cells from LN and blood in HIV-seronegative
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subjects (black), HIV+ CPs (red), and HIV+ ART+ subjects (blue). Wilcoxon tests were performed to compare differences between CD4+ and CD8+ T cells.  P < 0.01 and  P < 0.001.
(PDF)
S8 Fig. Functional characteristics of polyclonal CD4+ T cell responses in HIV-infected LNs
and blood. SPICE analysis of functional combination between LN (red) and PB (red-gray)
SEB stimulated CD4+ T cell responses for HIV-infected CPs and ART+ subjects. Median and
IQR are shown for all bar plots. Permutation test was performed between the pie charts. Wilcoxon matched-pairs single rank tests were performed to compare differences between two
matched groups;  P < 0.05.
(PDF)
S9 Fig. Functional characteristics of polyclonal and virus-specific LN and blood CD4+ T
cells. (A) IFNg and TNF co-expression by CMV-specific CD4+ T cells in LNs (left) and blood
(PB; right). (B) Degranulation (CD107) by T-bet+ SEB stimulated CD4+ T cells in LN and
blood. (C) Before-after graphs showing the frequency of CXCR5+ (left) and CXCR5hi HIVspecific CD4+ T cells between matched LN and blood. Wilcoxon matched-pairs single rank
tests were performed to compare differences between two matched groups;  P < 0.05;

P < 0.01 and  P < 0.001.
(PDF)
S10 Fig. Sorting and single-cell gene expression procedure of degranulating CD4+ T cells.
Sorting scheme to isolate single CD107+ SEB stimulated CD4+ T cells (left). Right plot shows
the correlation between single and bulk relative gene expression value (Log2) for every
assessed gene. Genes with an average of Log2>1.5 was used for further analysis in Fig 6. A
non-parametric Spearman test was used for the correlation analysis.
(PDF)
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